InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,106.98
(
0.84%
)
US TECH 100
17,399.20
(
1.89%
)
Dow Jones
38,552.38
(
0.85%
)
Brent Oil
83.23
(
-0.48%
)
Bitcoin
61,575.02
(
4.15%
)
Post# of 8512
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rod5247

Send PM Follow Ignore
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

rod5247

Re: friendofthedevil post# 3521

Friday, 10/03/2014 7:05:38 PM

Friday, October 03, 2014 7:05:38 PM

Post# of 8512
"PEGPH20 plus gemcitabine was well tolerated and showed promising efficacy in patients with high tumor HA, leading to the current clinical phase 2 study of PEGPH20 in combination with nab-paclitaxel and gemcitabine for the treatment of stage IV PDA."

What would prevent him from discussing data from the first year of the Phase II study?

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HALO News
More HALO News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!